Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Multicenter Trial Examining the Effect of Derm-Maxx ADM on the Healing Rate of Chronic Diabetic Foot Ulcers
Conditions
Interventions
Derm-Maxx
Locations
11
United States
North Alabama Research Center, LLC
Athens, Alabama, United States
Premium Podiatry
Encino, California, United States
Royal Research
Hollywood, Florida, United States
Bioresearch Partner
Miami, Florida, United States
Bioresearch Partner
Miami Lake, Florida, United States
Wahab Research
Las Vegas, Nevada, United States
Start Date
October 25, 2024
Primary Completion Date
October 31, 2025
Completion Date
October 31, 2025
Last Updated
April 30, 2025
NCT07039396
NCT07396376
NCT07116876
NCT07198061
NCT07014176
NCT07109895
Lead Sponsor
Capsicure, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions